Table 2.

N-linked glycans released from total plasma glycoprotein in longitudinal plasma samples from infants with galactosemia. Patient number, gender, age at blood draw, and gal-1P at blood draw are listed. None of these infants had detectable GALT activity in hemolysate.

Glycan structure	Reference range from 150 controls (%)	Initial	Follow-up			Initial	Follow-up	Initial	Follow-up
		P2# ♂	P2 ♂	P2 ♂	P2 ♂	P3# ♀	P3 ♀	P7# ♀	P7 ♀
		9 days (gal - 1P unk)	31 days (9.5 mg/dL)	59 days (5.3 mg/dL)	206 days (1.5 mg/dL)	8 days (15.7 mg/dL)	56 days (7.2 mg/dL)	13 days (52.4 mg/dL)	109 days (3.1 mg/dL)
	0.27-1.23	1.37	0.61	0.60	0.44	1.78*	0.64	1.09	0.67
	0.02-0.19	0.14	0.08	0.04	0.00	0.09	0.00	0.07	0.31
	0.25-0.92	0.90	0.45	0.48	0.24	1.20*	0.38	0.55	0.42
	0.00-0.14	0.06	0.11	0.08	0.07	0.00	0.00	0.07	0.12
	0.10-0.38	0.36	0.11	0.11	0.14	0.55	0.13	0.26	0.14
	0.21-0.59	0.40	0.40	0.47	0.49	0.70	0.50	0.49	0.48
	0.07-0.29	0.32	0.15	0.21	0.10	0.59**	0.14	0.25	0.08
	0.00-0.14	0.12	0.10	0.09	0.07	0.03	0.00	0.10	0.09
	0.08-0.49	0.27	0.15	0.15	0.11	0.38	0.17	0.19	0.20
	0.47-1.15	0.44	0.61	0.78	1.38	0.87	1.05	0.82	1.03
	0.00-0.11	0.05	0.08	0.13*	0.08	0.08	0.07	0.10	0.06
	0.14-0.52	0.14	0.16	0.22	0.21	0.44	0.30	0.20	0.22
	2.71-6.6	2.25	1.88*	3.05	4.27	4.05	3.65	2.86	2.72
	0.29-1.98	0.94	0.42	0.54	0.27	0.92	0.44	0.95	0.48
	10.91-20.43	6.73**	11.13	16.65	20.22	14.85	24.27**	14.12	16.69
	0.09-1.92	0.94	0.86	1.15	1.14	1.87	1.57	2.20*	1.26
	0.25-0.99	0.14*	0.10*	0.27	0.83	0.28	0.40	0.48	0.34
	0.00-0.32	0.08	0.06	0.10	0.18	0.35**	0.00	0.32**	0.20
	0.97-4.16	0.22*	0.52	1.05	2.86	0.80	1.29	0.85	1.36
	0.25-2.14	0.19	0.54	0.87	0.77	0.91	2.07	0.84	0.91

Glycan symbols, shading, and statistical significance: same as Table 1.